0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Lyrica - API Insight,2019
Published Date: March 2019
|
Report Code: DELV-Drug-312
Home | Market Reports |Health |Health Conditions |Pain Management
Lyrica API Insight 2019

Lyrica - API Insight,2019

Code: DELV-Drug-312
Report
March 2019
30 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

Introduction
DelveInsight's, “Lyrica - API Insight, 2019” report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Lyrica . The report also highlights the patent details of Lyrica .

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report
• A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
• Patent information around Lyrica in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Lyrica in United States, Europe, China and India
• The report contains historical and forecasted sales for Lyrica till 2021
• Enlists the market competition and emerging therapies in the space where Lyrica operates

Reasons to Buy
• Evaluate the marketing status of Lyrica to exploit opportunities for generic Lyrica development opportunities
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Lyrica
• API intelligence over Lyrica and gaining primary intelligence over Active Ingredient manufacturers by country
• Make more informed business decisions from insightful and in-depth analysis of the Lyrica 's performance

1. Lyrica Overview
2. Lyrica Global Sales Assessment
• Lyrica Historical Global Sales
• Lyrica Forecasted Global Sales
3. Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
4. Product Details by country
5. Patent Information
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
Appendix
Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Lyrica Historical Global Sales till 2018 (in million USD)
Table 2: Lyrica Forecasted Global Sales from 2019-2021 (in million USD)
Table 3: Lyrica General Description
Table 4: Product Details by country
Table 5: Patent Information
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region

List of Figures

Figure 1: Lyrica Historical Global Sales till 2018 (in million USD)
Figure 2: Lyrica Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: Lyrica Patent Details
Figure 4: API Manufacturers by Country
Figure 5: API Manufacturers by Region

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$500
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$1000
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$1500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Joint Pain Injections Sales Market Report 2021
Global Joint Pain Injections Sales Market Report 2021

Based on distribution channel the market has been segregated into hospital pharmacies retail pharmacies and online pharmacies.Market Analysis and Insights Global Joint Pain Injections MarketThe global Joint Pain Injections market was valued at US 2995 in 2020 and will reach US 4013.6 million by the end of 2027 growing at a CAGR of 5.0 during 20222027.Global Joint Pain Injections Scope and Market SizeThe global Joint Pain Injections market is segmented by company region country by Type and by Application.

120 Pages
Type: Report
Code: QYRE-Auto-38N5172
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Intravenous IV Ibuprofen Sales Market Report 2021
Global Intravenous (IV) Ibuprofen Sales Market Report 2021

Intravenous IV ibuprofen is a nonsteroidal antiinflammatory drug NSAID used to reduce or treat pain fever and inflammation occurred due to a disease operative procedures or trauma and acute illness.Market Analysis and Insights Global Intravenous IV Ibuprofen MarketThe global Intravenous IV Ibuprofen market was valued at US 8103.3 in 2020 and will reach US 15400 million by the end of 2027 growing at a CAGR of 11.3 during 20222027.Global Intravenous IV Ibuprofen Scope and Market SizeThe global Intravenous IV Ibuprofen market is segmented by company region country by Type and by Application.

120 Pages
Type: Report
Code: QYRE-Auto-19A5224
Mon Jun 14 00:00:00 UTC 2021

Add to Cart

Global Acute Migraine Drugs Market Insights and Forecast to 2027
Global Acute Migraine Drugs Market Insights and Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15T1655
Thu Jun 10 00:00:00 UTC 2021

Add to Cart

Global Pain Relief Patches Market Insights and Forecast to 2027
Global Pain Relief Patches Market Insights and Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-4304
Mon May 31 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0